Despite a downward slide over the last several quarters, things seem to be looking up for venture capital investments in the life sciences — at least anecdotally.
The latest example is a new $250 million fund raised by 5AM Ventures, which invests in early-stage life science companies, primarily those focused on the discovery and development of therapeutics.
Image Courtesy of ddpavumba / FreeDigitalPhotos.net
To read the original article: Healthcare VC on the rebound? 5AM Ventures raises biggest fund yet
